US equities
|
MU
$877.55
▲+0.00%
TSLA
$372.22
▲+0.00%
SNDK
$1,238.03
▲+0.00%
NBIS
$158.74
▲+0.00%
SPCX
$147.49
▲+0.00%
NVDA
$210.96
▲+0.00%
AMD
$516.79
▲+0.00%
INTC
$86.96
▲+0.00%
MU
$877.55
▲+0.00%
TSLA
$372.22
▲+0.00%
SNDK
$1,238.03
▲+0.00%
NBIS
$158.74
▲+0.00%
SPCX
$147.49
▲+0.00%
NVDA
$210.96
▲+0.00%
AMD
$516.79
▲+0.00%
INTC
$86.96
▲+0.00%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Galmed Pharmaceuticals Ltd. - Ordinary Shares
(NQ:
GLMD
)
4.630
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Sep 9, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Galmed Pharmaceuticals Ltd. - Ordinary Shares
MarketBeat Week in Review – 9/16 - 9/20
September 21, 2024
Stocks got a boost as the Federal Reserve cut interest rates, but investors should expect more volatility as economic data continues to deliver mixed signals
Via
MarketBeat
Topics
Economy
How Critical Demand for Metastatic Breast Cancer Therapies is Producing a Multi-Billion Dollar Opportunity for Biotechs
September 20, 2024
EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NYSE:NVS),(NYSE:MRK),(NYSE:PFE),(NASDAQ:GLMD) EQNX::TICKER_END
Via
FinancialNewsMedia
How Critical Demand for Metastatic Breast Cancer Therapies is Producing a Multi-Billion Dollar Opportunity for Biotechs
September 20, 2024
From
FN Media Group LLC
Via
GlobeNewswire
Galmed Pharmaceuticals Surges 400%: What's Behind the Explosion?
September 17, 2024
Galmed Pharmaceuticals (NASDAQ: GLMD) stock skyrocketed nearly 400%, trading over 80 million shares, compared to its average of 75,000.
Via
MarketBeat